Our Portfolio

The University of Texas Southwestern Medical Center at Dallas

Ilya Bezprozvanny, PhD | Texas, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $100,000 Funding Amount
  • 12/1/09 — 5/2/11 Project Duration
  • Drug Discovery Program
  • Target Validation Therapeutic Stage
  • Closed Status

The University of Texas Southwestern Medical Center at Dallas

Ilya Bezprozvanny, PhD | Texas, United States

Ryanodine receptor type 2 as a target for AD

The main goal of the proposed project is to evaluate if clinically relevant inhibitor of intracellular calcium channels has a therapeutic potential for treatment of AD

GET IN TOUCH